# Clinical Trial of the Safety and Efficacy of SP160412 in the Temporary Relief of Mild to Moderate Sunburn

> **NCT03332524** · PHASE2 · TERMINATED · sponsor: **Sephoris Pharmaceuticals LLC** · enrollment: 80 (actual)

## Conditions studied

- Sunburn

## Interventions

- **DRUG:** SP160412 Ibuprofen 400 mg and Chlorpheniramine maleate 4 mg
- **DRUG:** 2 capsules Ibuprofen and 1 placebo
- **DRUG:** capsule Chlorpheniramine 4mg and 1 Placebo

## Key facts

- **NCT ID:** NCT03332524
- **Lead sponsor:** Sephoris Pharmaceuticals LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-01-15
- **Primary completion:** 2019-09-25
- **Final completion:** 2019-09-25
- **Target enrollment:** 80 (ACTUAL)
- **Why stopped:** Sponsor decided to stop for lack of efficacy
- **Last updated:** 2019-09-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03332524

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03332524, "Clinical Trial of the Safety and Efficacy of SP160412 in the Temporary Relief of Mild to Moderate Sunburn". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT03332524. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*